Maitake ('dancing mushroom' in Japanese) contains D-fraction beta-glucan that has immune-modulating and anti-cancer research. A 2009 Memorial Sloan Kettering study found maitake D-fraction enhanced NK cell activity by 1.5-2.6x in breast cancer patients. Also shows evidence for blood sugar reduction (improved insulin sensitivity). Grifolan (the specific beta-glucan) activates dendritic cells via dectin-1 receptor. Dose: 3-7mg/day D-fraction extract or 500-1,500mg whole mushroom. --- *Reviewed by the Dose AI Research Team and Clinical Advisory Board* *Last updated: 2026-04-06*
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.